Ambulantes Operationszentrum München-Giesing
Medical Technology · Rosenheim
Ambulantes Operationszentrum München-Giesing is a medical technology company based in Rosenheim, Germany. The company operates in the German medical devices market under the EU Medical Device Regulation (MDR 2017/745).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
Ambulantes Operationszentrum München-Giesing Address & Contact
Website
Ambulantes Operationszentrum München-Giesing Overview
The Ambulantes Operationszentrum München-Giesing is a specialized facility for outpatient surgical procedures that prioritizes the needs of patients through its innovative approach. The center promotes modern medical technology and employs advanced procedures to ensure optimal treatment outcomes. Located in Rosenheim, just a few kilometers from Munich, it offers patients the benefits of urban healthcare while simultaneously providing the advantages of a specialized, patient-centered outpatient facility.
Services and Products
The range of services offered by the Ambulantes Operationszentrum includes a variety of outpatient surgeries across different specialties, including:
- General Surgery: This includes procedures such as abdominal surgeries, which are often performed minimally invasively.
- Orthopedics: The center offers treatments for joint issues, tendon injuries, and arthroscopic procedures to alleviate discomfort.
- Ear, Nose, and Throat (ENT): Procedures in this area range from simple tonsillectomies to complex nasal surgeries.
- Urology: The Ambulantes Operationszentrum also performs urological procedures, which often involve routine treatments.
- Gynecology: This includes interventional procedures specifically tailored to the needs of women.
Patients benefit from short waiting times and modern surgical techniques, complemented by rapid rehabilitation and optimal aftercare. The goal is to provide patients with first-class medical care where they can spend more time in their familiar environment.
Regulatory Classification
The Ambulantes Operationszentrum München-Giesing meets all requirements of the relevant health authorities and is certified according to the applicable standards for outpatient facilities. This ensures that all medical procedures are carried out in accordance with strict quality guidelines and safety standards. The facility is also bound by the framework conditions of the Social Code as well as the guidelines of the regional medical associations to ensure legal and quality standards in healthcare.
Location Rosenheim / Bavaria
Rosenheim, located in the picturesque Upper Bavaria, plays a central role in the healthcare provision of the region. Due to its good transport links via highways and the train station, the Ambulantes Operationszentrum is easily accessible for patients from the Greater Munich area as well as residents of the city itself. The city is not only an important supply center but also a location with a high quality of life, making it particularly attractive to healthcare professionals. The regional significance of the center extends beyond the borders of Rosenheim, as it attracts patients from all over Upper Bavaria who value specialized outpatient treatments.
Special Features of the Ambulantes Operationszentrum
The Ambulantes Operationszentrum München-Giesing stands out due to its patient-centered philosophy and the use of the latest technologies. It is committed to optimizing the patient experience from admission to discharge. The highly qualified team of surgeons, anesthetists, and nursing staff ensures that each procedure is performed under optimal conditions. Additionally, the facility offers personalized and individual care that prioritizes the well-being of the patients. These factors significantly contribute to a high level of patient satisfaction.
Other medical technology companies in the region: Medical Technology in Bavaria or all Medical Technology in Germany on Sanoliste.
```Frequently asked questions about Ambulantes Operationszentrum München-Giesing
What does Ambulantes Operationszentrum München-Giesing do?
Ambulantes Operationszentrum München-Giesing is a company in the medical technology sector based in Rosenheim. The company develops, produces or distributes medical devices, instruments or systems for use in healthcare facilities.
Where is Ambulantes Operationszentrum München-Giesing located?
Ambulantes Operationszentrum München-Giesing is headquartered in Rosenheim. More information can be found on the company's website.
In which area of medical technology is Ambulantes Operationszentrum München-Giesing active?
Ambulantes Operationszentrum München-Giesing is active in the medical technology sector and offers solutions for medical facilities, clinics and practices. You can find the exact areas of focus on the company's website.
Ambulantes Operationszentrum München-Giesing on social media
More Medical Technology in Rosenheim
Medical Technology in Germany
Related areas in healthcare
Medical Technology by location
About Medical Technology
Germany's medical technology sector is one of the most important in the world. With annual revenues of approximately EUR 36 billion and more than 1,400 companies, Germany ranks as the third-largest medical technology market globally (SPECTARIS 2023), after the United States and Japan. The sector encompasses the development, manufacture and distribution of an extraordinarily wide range of products: in-vitro diagnostic (IVD) devices, medical imaging systems (CT, MRI, ultrasound), implants such as hip and knee prostheses, cardiac pacemakers, surgical instruments, hospital beds, wound care products and medical software classified as a Software as a Medical Device (SaMD). In Germany and across the European Union, medical devices must comply with the EU Medical Device Regulation (MDR 2017/745), which replaced the former Medical Devices Directive (MDD 93/42/EEC). Devices are classified into risk classes I, IIa, IIb and III. Higher-risk classes require a conformity assessment by a designated Notified Body (benannte Stelle) before a CE mark can be affixed. The CE mark signals that the product meets EU safety, performance and quality requirements and may be placed on the European market. Key medtech clusters in Germany include the Munich and Nuremberg region in Bavaria, the Rhine-Main area in Hesse, Tuttlingen in Baden-Württemberg (known as the world capital of surgical instruments) and the Hamburg metropolitan area. This directory lists CE-certified manufacturers, distributors and suppliers across the German medtech sector with full contact details.
Germany as a Global Medical Technology Hub
Germany's position as the world's third-largest medical technology market is underpinned by a combination of industrial engineering excellence, a well-funded healthcare system and a highly productive research landscape. The German medtech sector is characterised by a large number of small and medium-sized enterprises (SMEs) that are often hidden champions (Weltmarktführer) in specialised niches. Unlike the pharmaceutical sector, where large corporations dominate, the medtech industry is more fragmented and innovative, with frequent spin-offs from university hospitals and engineering faculties. Key product categories include imaging systems (MRI, CT, X-ray, ultrasound), endoscopy and minimally invasive surgical tools, orthopaedic implants, cardiovascular devices, in-vitro diagnostics, dental equipment, ophthalmic devices, wound care systems and hospital IT and medical software. Germany is particularly renowned for its surgical instrument manufacturing, centred in Tuttlingen, Baden-Württemberg, which supplies operating theatres worldwide. The annual Medica trade fair in Düsseldorf is the world's largest medical technology exhibition and serves as a global industry showcase.
EU MDR Compliance and CE Marking for German Manufacturers
The EU Medical Device Regulation (MDR 2017/745) replaced the former Medical Devices Directive (MDD 93/42/EEC) and has applied in full since May 2021, with transition periods for legacy devices extended to 2028 in some cases. For German manufacturers selling in the EU market, MDR compliance is a legal necessity. The regulation introduced significantly strengthened requirements compared to the old MDD: more rigorous clinical evidence requirements, mandatory post-market clinical follow-up (PMCF), unique device identification (UDI) registration in the EUDAMED database, increased obligations for Notified Bodies, and stricter rules for software as a medical device (SaMD). The risk classification system under MDR uses four classes (I, IIa, IIb, III) based on the intended purpose, duration of use and body contact of the device. Manufacturers must appoint an authorised representative in the EU if they are not themselves based in an EU member state, and they must maintain a quality management system. In Germany, the Bundesnetzagentur and state authorities support MDR enforcement alongside BfArM.
Innovation and Research in German Medtech
Germany's medtech innovation ecosystem benefits from close collaboration between industry, university hospitals (Universitätsklinika), applied research institutes (such as those of the Fraunhofer and Helmholtz networks) and health technology assessment bodies. The Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) and the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) play important roles in assessing which new medical technologies are eligible for reimbursement by statutory health insurance (GKV). This reimbursement pathway, known as the NUB process (Neue Untersuchungs- und Behandlungsmethoden) for hospital technologies, is a key milestone for commercial success in Germany. Innovative devices that receive a positive NUB assessment can be reimbursed at negotiated rates by statutory insurers, providing a significant market access advantage.
Innovation Fields and Future Technologies
The German medical technology sector is driving numerous future fields forward. AI-supported diagnostics and image analysis are revolutionising radiology and pathology; algorithms for the early detection of cancer and cardiovascular disease are increasingly receiving CE approvals as Software as a Medical Device (SaMD). Robot-assisted surgical systems, led by products from Siemens Healthineers, Brainlab and Karl Storz, are improving precision in complex procedures. Minimally invasive technologies, implantable pacemakers and intelligent prostheses with sensory feedback demonstrate the breadth of innovation. Point-of-care diagnostics enables rapid tests directly in the doctor's surgery or at the bedside. Telemedicine and digital patient records promote networking between medical devices and clinical workflows. The Federal Ministry of Education and Research (BMBF) funding programme specifically supports the development of innovative medical technology products through cooperation between industry and universities.
What does the medical technology sector cover?
Medical technology encompasses the development, manufacture and distribution of medical devices, instruments, software and accessories used to diagnose, prevent, monitor or treat diseases. Germany ranks among the world's leading medical technology hubs.
How are medical devices approved in Germany?
Medical devices in Germany and the EU must comply with the EU Medical Device Regulation (MDR 2017/745) and carry the CE mark. Depending on the risk class, conformity assessments by notified bodies are required.
Where can I find medical technology companies in Germany?
Medical technology companies in Germany can be found through industry associations such as SPECTARIS, BVMed or ZVEI, and via the EUDAMED EU database for registered manufacturers. Sanoliste provides a searchable directory of manufacturers, distributors and suppliers across the German medical technology sector.
How many medical technology companies are there in Germany?
Germany has more than 1,400 medical technology companies generating annual revenues of approximately EUR 36 billion (SPECTARIS 2023), making it the third-largest medical technology market in the world. The majority of companies are small and medium-sized enterprises (SMEs), many of which are world market leaders in their niche.
What are the risk classes for medical devices under the EU MDR?
The EU Medical Device Regulation (MDR 2017/745) classifies medical devices into four risk classes: Class I (lowest risk, e.g. bandages, glasses frames), Class IIa (medium risk, e.g. hearing aids, contact lenses), Class IIb (higher medium risk, e.g. infusion pumps, ventilators) and Class III (highest risk, e.g. implantable cardiac devices, neurosurgical instruments). Higher classes require more rigorous conformity assessment by a Notified Body.
Where are the main medical technology clusters in Germany?
Germany's medical technology industry is concentrated in several regional clusters. Bavaria (particularly Munich and Nuremberg) and Baden-Württemberg (notably Tuttlingen, globally known for surgical instruments) are the two strongest regions. Other significant clusters include the Rhine-Main area in Hesse, the Hamburg metropolitan region, the Ruhr area in North Rhine-Westphalia and the Berlin-Brandenburg region.
What is a Notified Body (benannte Stelle) and why does it matter?
A Notified Body (benannte Stelle) is an independent third-party organisation designated by an EU member state to assess whether medical devices meet the requirements of the MDR before they can carry the CE mark. For Class IIa, IIb and III devices, manufacturers must have their quality management system and technical documentation assessed by a Notified Body. In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) oversees market surveillance, while several German organisations hold Notified Body status under the MDR.